Prialt Injection, Solution
NDC Package 70720-720-10
Package Information
Prialt (ziconotide acetate) injection is a medication a non-opioid pain reliever that is used to treat ongoing pain when other treatments or medications cannot control your pain. This formulation utilizes a injection, solution delivery system. Marketed by Tersera Therapeutics Llc, this product is identified by NDC 70720-720 and is authorized under FDA application NDA021060.
Identification & Billing
- RxCUI: 1738353 - ziconotide 100 MCG in 1 ML Injection
- RxCUI: 1738353 - 1 ML ziconotide acetate 0.1 MG/ML Injection
- RxCUI: 1738353 - ziconotide 100 MCG per 1 ML Injection
- RxCUI: 1738354 - prialt 100 MCG in 1 ML Injection
- RxCUI: 1738354 - 1 ML ziconotide acetate 0.1 MG/ML Injection [Prialt]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70720 - Tersera Therapeutics Llc
- 70720-720 - Prialt
- 70720-720-10 - 1 VIAL, GLASS in 1 CARTON / 1 mL in 1 VIAL, GLASS
- 70720-720 - Prialt
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70720-720-10 identifies a specific commercial package of 1 vial, glass in 1 carton / 1 ml in 1 vial, glass of Prialt, a human prescription drug labeled by Tersera Therapeutics Llc. This injection, solution is formulated for intrathecal use and contains ziconotide acetate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Tersera Therapeutics Llc on October 15, 2018. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is a non-opioid pain reliever that is used to treat ongoing pain when other treatments or medications cannot control your pain. Ziconotide works by blocking the nerves in the spinal cord that send pain signals. It decreases ongoing pain caused by cancer, AIDS, failed back surgery, multiple sclerosis, neuropathy, and other causes.
How is this Tersera Therapeutics Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70720072010. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
